Literature DB >> 24825990

Midazolam premedication in attenuating ketamine psychic sequelae.

S C Somashekara1, D Govindadas1, G Devashankaraiah1, Rajkishore Mahato1, S Deepalaxmi2, V Srinivas3, J V Murugesh3.   

Abstract

The objective of the study was to evaluate the effectiveness of midazolam premedication in attenuating the psychic sequelae of ketamine dissociative anaesthesia. Sixty patients undergoing various short surgical and urological procedures were taken in the study. All patients were premedicated with midazolam (0.05mg/kg i.v) five minutes before ketamine induction (1mg/kg i.v). The excitatory phenomenon, emergence delirium, occurrence of unpleasant dreams and patient acceptability of ketamine anaesthesia were recorded. Out of 60 patients studied, 15% had excitatory effects, 8% had mild delirium and 3% patients had unpleasant dreams in post operative period. Patient acceptability of ketamine anaesthesia was 100%. Hence from the study it was concluded that, midazolam premedication is effective in attenuating ketamine psychic sequelae.

Entities:  

Keywords:  Dissociative anaesthesia; Ketamine; Midazolam; Preaneasthetic medication

Year:  2010        PMID: 24825990      PMCID: PMC3979212     

Source DB:  PubMed          Journal:  J Basic Clin Pharm        ISSN: 0976-0113


  4 in total

1.  Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study.

Authors:  Deepa Kameswari Perumal; Mangaiarkkarasi Adhimoolam; Nitya Selvaraj; Suneeth Pullikotil Lazarus; Meher Ali Raja Mohammed
Journal:  J Res Pharm Pract       Date:  2015 Apr-Jun

2.  Influence of Difference in Timing of Perioperative Administration of Low-dose Ketamine on Postoperative Analgesia.

Authors:  Ragi Jain; Namrata Kochhar
Journal:  Anesth Essays Res       Date:  2017 Apr-Jun

Review 3.  Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.

Authors:  Felicia Ceban; Joshua D Rosenblat; Kevin Kratiuk; Yena Lee; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Flora Nasri; Leanna M W Lui; Orly Lipsitz; Anil Kumar; Jung Goo Lee; Edmond H Chau; Bing Cao; Kangguang Lin; Roger C Ho; Rodrigo B Mansur; Jennifer Swainson; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-08-07       Impact factor: 5.749

4.  Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation.

Authors:  Poorvi Shah; Marc McDowell; Reika Ebisu; Tabassum Hanif; Theodore Toerne
Journal:  J Med Toxicol       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.